Products

Acceleron is dedicated to bringing life-changing and important agents to our patients. Acceleron’s strategy was designed to advance biotherapeutic products as rapidly and efficiently as possible. The robust pipeline we have built in the short time since our inception is evidence of our productivity and dedication:

	Research	Pre-Clinical	Pre-IND	Phase 1	Phase 2
Bone Loss (Multiple Myeloma, Cancer-Related Bone Loss)
ACE-011
ACE-05X
Muscle Loss (Muscular Dystrophy, Cancer-Related Muscle Loss)
ACE-031
ACE-08X
Anti-angiogenesis (Solid Tumors, Multiple Myeloma)
ACE-041
Metabolic Disorders (Type 2 Diabetes, Obesity)
ACE-06X